Altria’s Dividend Yield Signals Doubts About the Payout. Why It’s Safe.

The FDA’s bid to ban Juul products—like these at a shop in El Segundo, Calif., on a recent day—has weighed

Read more

Altria Shakes Off a Sell Rating and Gets an Upgrade

Text size Rising macroeconomic uncertainty contributed to a downgrade of Altria’s stock in early June. Fabrice Coffrini/AFP via Getty Images

Read more

The FDA Bans Juul Vapes. What Now for Altria’s Investment?

Text size Juul can appeal the FDA ban if it chooses. Mario Tama/Getty Images The Food and Drug Administration has

Read more

Juul Ban Will Send Altria’s Strategy, and $13 Billion, Up in Smoke

Juul Labs was on pace to make 94% of its revenue in the U.S. this year. Photo: Seth Wenig/Associated Press

Read more

Altria Stock Gets a Downgrade. Why Gas Prices Are Partly to Blame.

Text size Analyst Pamela Kaufman lowered her price target to $50 from $54. Illustration by Joel Arbaje Altria Group stock

Read more